Switch View
© Globe Newswire
14.10.2025
ISIN: US15117F3029
Cellectar Biosciences, Inc.
CLRB
LISTED
NASDAQ
Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research
News Preview
CLR 225 (225Ac-phospholipid ether) Demonstrates Meaningful Inhibition of Tumor Growth and Potential Survival Benefit In Three Pancreatic Cancer Xenograft Models CLR 225 (225Ac-phospholipid ether) Demonstrates Meaningful Inhibition of Tumor Growth and Potential Survival Benefit In Three Pancreatic Cancer Xenograft Models...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US59503A2042
Microbot Medical Inc.
MBOT
LISTED
NASDAQ
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
News Preview
The Experienced MedTech Logistics Provider Will Help Ensure Effective and Efficient Inventory Management and Customer Support The Company is on Track to Commence the Launch of LIBERTY® during Q4 This Year...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
News Preview
Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
14.10.2025
ISIN: IE00BF3W0Q35
Iterum Therapeutics Plc
ITRM
LISTED
NASDAQ
Iterum Therapeutics to Present Data at IDWeek 2025
News Preview
DUBLIN and CHICAGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that two posters will be presented at the Infectio...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
14.10.2025
ISIN: US01626L1052
Aligos Therapeutics, Inc.
ALGS
LISTED
NASDAQ
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that members of management will present at the H.C. Wainwright Liver Disease Confere...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025
News Preview
Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2025 of $1.30 per share on the company’s common stock. The dividend is payable on December 9, 2025 to shareholders of record at the close of business on November 25, 2025. The ex-dividend date is November 25, 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
News Preview
Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the Company’s intent to separate its Orthopaedics business to enhance the strategic and operational focus of each company and drive value for stakeholders.
The intended separation would further strengthen the focus of Johnson & Johnson as an innovation powerhouse, serving area...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook
News Preview
Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2025. “Johnson & Johnson delivered another strong performance in the third quarter fueled by the depth and strength of our portfolio and significant progress across our pipeline,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “With a...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US1374041093
Candel Therapeutics, Inc.
CADL
LISTED
NASDAQ
Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
News Preview
NEEDHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that it has entered into a five-year, $130 million term loan facility with Trinity...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US1374041093
Candel Therapeutics, Inc.
CADL
LISTED
NASDAQ
Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine
News Preview
NEEDHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced encouraging interim data from its ongoing phase 1b clinical trial of CAN-3110 (lin...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: KYG8807B1068
Theravance Biopharma Inc
TBPH
LISTED
NASDAQ
Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting
News Preview
A retrospective cohort study of claims data demonstrated that following hospital discharge, patients adherent to YUPELRI experienced significantly fewer, and less severe, exacerbations and had significantly lower healthcare costs than non-adherent patients
Post-hoc analyses of a Phase 3 safety s...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: SGXZ17669631
CytoMed Therapeutics Limited
GDTC
LISTED
NASDAQ
CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets
News Preview
SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, includi...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
14.10.2025
ISIN: US87427V1035
Talkspace Inc
TALK
LISTED
NASDAQ
Talkspace to Report Third Quarter 2025 Results and Host Conference Call
News Preview
NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Talkspace (Nasdaq: TALK), a leading online behavioral health care company, today announced that it will release its third quarter 2025 results on Thursday, October 30, 2025 before market open and host a conference call to review the results at 8:30am ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US67577R1023
Opus Genetics, Inc.
IRD
LISTED
NASDAQ
Opus Genetics to Participate in Chardan's 9th Annual Genetic Medicines Conference
News Preview
Opus Genetics to Participate in Chardan's 9th Annual Genetic Medicines Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US62855J1043
Myriad Genetics Inc
MYGN
LISTED
NASDAQ
Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel
News Preview
The Foresight® Carrier Screen includes all conditions recommended by the American College of Medical Genetics and Genomics recommendations The Foresight® Carrier Screen includes all conditions recommended by the American College of Medical Genetics and Genomics recommendations...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US35104E1001
4D Molecular Therapeutics Inc
FDMT
LISTED
NASDAQ
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
News Preview
EMERYVILLE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will par...
Themefolio
Profiler
Peergroup
© Newsfile
14.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Announces New Franchise Agreement and Real Estate Secured for Heal Wellness in Airdrie, Alberta
News Preview
Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada, is pleased to announce the signing of a new franchise agreement and secured real estate for Heal Wellness ("Heal") in Airdrie, Alberta...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: NL0011606264
Merus N.V.
MRUS
LISTED
NASDAQ
Merus Announces Publication of an Abstract on Petosemtamab in Metastatic Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
News Preview
- Petosemtamab in combination with FOLFOX /FOLFIRI (1L and 2L mCRC) and as monotherapy (3L+ mCRC), demonstrates antitumor activity and a manageable safety profile...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US3596161097
Fulcrum Therapeutics Inc
FULC
LISTED
NASDAQ
Fulcrum Therapeutics to Present Preclinical Data for EED Inhibitor FTX-6274 at European Society for Medical Oncology (ESMO) Congress 2025
News Preview
― Preclinical data of FTX-6274 suggests potential for the treatment of castration resistant prostate cancer ―...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US45782T1051
INmune Bio, Inc.
INMB
LISTED
NASDAQ
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
News Preview
Boca Raton, FL, Oct. 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces that David Moss, Chief Executive Officer will participate in a Dermatologic Rare Disease Panel at the Maxim Growth Summit presented by Maxim Group LLC. The Summit is being held on October 22 – 2...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US7867001049
Sagimet Biosciences Inc
SGMT
LISTED
NASDAQ
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
News Preview
SAN MATEO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in three upcoming investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US0453961080
Assembly Biosciences, Inc.
ASMB
LISTED
XETRA
Assembly Biosciences Announces Upcoming Investor Conference Participation
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the company will participate in fireside chats at two upcoming investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US44975P1030
I-Mab
IMAB
LISTED
NASDAQ
I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
News Preview
ROCKVILLE, Md., Oct. 14, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ:IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that an abstract related to updated data from the Phase 1 study of givastomig as a monotherapy in heavily pre-treated...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US4037831033
Gyre Therapeutics Inc
CBIO
LISTED
NASDAQ
Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025
News Preview
Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US68232V8019
Traws Pharma Inc.
TRAW
LISTED
NASDAQ
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
News Preview
Non-inferiority trial versus PAXLOVID® assessing safety and efficacy, including rates of disease rebound and incidence of Long COVID development, of ratutrelvir, a ritonavir-free anti-viral treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US09058V1035
BioCryst Pharmaceuticals Inc
BCRX
LISTED
NASDAQ
BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile
News Preview
– Deal to add navenibart, a late-stage and long-acting plasma kallikrein inhibitor, in Phase 3 clinical development, to BioCryst’s HAE portfolio –...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US6551872012
Aclarion, Inc.
ACON
LISTED
NASDAQ
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst
News Preview
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US69404D1081
Pacific Biosciences of California Inc
PACB
LISTED
NASDAQ
PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities
News Preview
New SPRQ-Nx chemistry designed to deliver the most complete view of the genome for less than $300 at scale New SPRQ-Nx chemistry designed to deliver the most complete view of the genome for less than $300 at scale...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US87918A1051
Teladoc Health Inc
TDOC
LISTED
NYSE
Teladoc Health Adds Workplace Safety Capability to its AI-Enabled Clarity™ Monitoring Solution for Hospitals and Health Systems
News Preview
New offering aims to address the growing threat of workplace violence in healthcare settings, building on Teladoc Health's suite of AI-enabled solutions....
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
First patient treated with Leqembi® (lecanemab) in the Nordics
News Preview
STOCKHOLM, Oct. 14, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that Leqembi has now been made available at a private clinic in Finland and that the first patient has started treatment. BioArctic copromotes Leqembi with its partner Eisai in the Nordic countries, and this ma...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.10.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC PINK:MDCE) Accelerates Growth Trajectory as Its Diverse AI Ecosystem Eyes $450 Billion in Multi-Market Potential
News Preview
MESA, ARIZONA / ACCESS Newswire / October 14, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that its patent pending artificial-intelligence platform-initially engineered for medical diagnostics-has demonstrated exceptional adaptability across multiple industries, including personal health tracking, fitness analytics, diet op...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.10.2025
ISIN: US45408X3089
IGC Pharma, Inc
IGC
LISTED
XASE
IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of South Florida's Department of Psychiatry and Behavioral Neurosciences
News Preview
POTOMAC, MD, 1734 / ACCESS Newswire / October 14, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced the expansion of its ongoing Phase 2 CALMA clinical trial...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides an update on its commercial and operational performance for the quarter ended 30 September 2025 (Q3 2025). All figures are in USD unless stated otherwise....
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
NUTX Deadline: NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: N...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.10.2025
ISIN: US92829J2033
Virios Therapeutics Inc
DWTX
LISTED
NASDAQ
Dogwood Therapeutics to Participate at the Maxim Growth Summit 2025
News Preview
ATLANTA, GA, GA / ACCESS Newswire / October 14, 2025 / Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company developing new medicines to treat pain and neuropathic disorders, today announces that Greg Duncan, Chief Executive Officer will participate at the Maxim Growth Summit presented by Maxi...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.10.2025
ISIN: US83558L2043
Sonoma Pharmaceuticals, Inc.
SNOA
LISTED
NASDAQ
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals
News Preview
BOULDER, CO, AL / ACCESS Newswire / October 14, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader in developing and producing stabilized hypochlorous acid (HOCl) products based on its patented Microcyn® technology, today announced the launch of a new HOCl wound cleanser manufactured by Sonoma for Medline Industries,...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: KYG4672N1198
HUTCHMED (China) Ltd
13
LISTED
HKSE
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
News Preview
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM:HCM, HKEX:13) today announces that Professor Tan Shao Weng, Daniel (Chen Shaowen) is appointed as an Independent Non-executive Director and a member of the Technical Committee of the Company with ef...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.10.2025
ISIN: CA58471K2020
Medicus Pharma Ltd.
MDCX
LISTED
TSX
Three Biotech Companies Redefining Value Creation Through Dual Strategies
News Preview
The Rise of Multi-Dimensional Biotech BRISTOL, TN, TN / ACCESS Newswire / October 14, 2025 / For decades, biotechnology investing was a binary game - a single trial failure could erase years of progress and billions in shareholder value. Yet a new generation of public life sciences companies is rewriting that equation by diversifying not just produ...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.10.2025
ISIN: US42227W1080
Healthcare Triangle, Inc.
HCTI
LISTED
NASDAQ
Healthcare Triangle's Strategic Intent Rewarded with a 32% Share Gain Since September (NASDAQ:HCTI)
News Preview
PLEASANTON, CA / ACCESS Newswire / October 14, 2025 / The market always appreciates a great company story. The problem is that it often rewards the ones that sound big, not necessarily the ones that are big. Healthcare Triangle Inc. (NASDAQ:HCTI) has decided to flip that script. It's no longer selling a dream; it's selling proof. And in a smallcap...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion publishes Interim Report for January–September 2025 and holds a webcast on 28 October 2025
News Preview
ORION CORPORATION PRESS RELEASE 14 OCTOBER 2025 at 11.15 EEST ...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.10.2025
ISIN: CA58471K2020
Medicus Pharma Ltd.
MDCX
LISTED
TSX
The Vanderbilt Report: Medicus Pharma Ltd Built Three Separate Billion-Dollar Bets
News Preview
BRISTOL, TN, NY / ACCESS Newswire / October 14, 2025 / Most biotech stories collapse on a single product failure. Medicus Pharma Ltd (NASDAQ:MDCX) built three distinct shots at blockbuster markets.The NASDAQ-listed company is developing Skinject, a dissolvable microneedle array delivering doxorubicin for basal cell carcinoma [1]. It acquired Tevere...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.10.2025
ISIN: US87975F1049
Telomir Pharmaceuticals, Inc.
TELO
LISTED
NASDAQ
Telomir Pharmaceuticals Announces New Data Showing That Telomir-1 Kills Aggressive Pancreatic Cancer Cells, One of the Deadliest Forms of Cancer
News Preview
Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1's consistent impact on cancer cell survival pathways. MIAMI, FLORIDA / ACCESS Newswire / October 14, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a precli...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: CNE1000048G6
Remegen Co., Ltd.
9995
LISTED
HKSE
2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China
News Preview
In the results of China Phase III clinical trial announced at the 2025 ACR, Telitacicept demonstrated statistically significant and clinically meaningful improvements in ESSDAI [EULAR (European League Against Rheumatism) Sjögren's Syndrome Disease Activity Index] compared to placebo.
Telitacicep...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: CNE1000048G6
Remegen Co., Ltd.
9995
LISTED
HKSE
2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China
News Preview
In the results of China Phase III clinical trial announced at the 2025 ACR, Telitacicept demonstrated statistically significant and clinically meaningful improvements in ESSDAI [EULAR (European League Against Rheumatism) Sjögren's Syndrome Disease Activity Index] compared to placebo.
Telitacicep...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025
News Preview
STOCKHOLM, Oct. 14, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi Iqlik, a subcutaneous autoinjector formulation of lecanemab (generic name), for the treatment of Alzheimer's disease has been selected by TIME as one of the 'Best Inventions of 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025
News Preview
STOCKHOLM, Oct. 14, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi Iqlik, a subcutaneous autoinjector formulation of lecanemab (generic name), for the treatment of Alzheimer's disease has been selected by TIME as one of the 'Best Inventions of 2025...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.10.2025
ISIN: US12482V1035
CBD Life Sciences Inc.
CBDL
LISTED
OTC
CBD Life Sciences Inc. (CBDL) Lands Major Order from Bronx Dispensary "Smoking Scholars," Signaling Explosive Growth Ahead for CBD-Infused Drinks Division
News Preview
Strong consumer demand and rapid market adoption drive CBDL's beverage expansion as top-selling CBD Lemonade, Raspberry Lemonade, and Lavender Lemonade hit the shelves of Smoking Scholars in New York City - setting the stage for record-breaking revenue in Q4 and beyond. SCOTTSDALE, AZ, AZ / ACCESS Newswire / October 14, 2025 / CBD Life Sciences Inc...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: FR0010331421
Innate Pharma SA
IPH
LISTED
EURONEXT
Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025
News Preview
Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that it will host an analyst and investor event focused on lacutamab, an asset with path to potential Accelerated Approval based on existing long-term follow-up data of the Phase 2 TELLOMAK study, providing both clinical perspectives...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: FR0010557264
AB Science SA
AB
LISTED
EURONEXT
AB Science will hold a virtual conference on Thursday, October 16, 2025 from 2pm to 3pm CET to provide an update on the Phase 1 study with AB8939
News Preview
PRESS RELEASE...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.10.2025
ISIN: CA98980M1095
Zomedica Corporation
ZOM
LISTED
XASE
Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union
News Preview
Expanded agreement strengthens Zomedica's European presence, broadens product portfolio on the market, and positions the Company to capture growth in the multi-billion-dollar global veterinary diagnostics and therapeutic device markets ANN ARBOR, MI, MI / ACCESS Newswire / October 14, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an update on its commercial and operational performance for the quarter ended 30 September 2025 (Q3 2025). All figures are in USD unless stated otherwise....
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: KYG3224E1061
Everest Medicines Limited
1952
LISTED
HKSE
Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14
News Preview
SHANGHAI, Oct. 14, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that the first patient has been enrolled in a global m...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US4718711033
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 13, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (N...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNO
News Preview
NEW YORK, Oct. 13, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf o...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"
News Preview
TOKYO and CAMBRIDGE, Mass., Oct. 13, 2025 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that LEQEMBI® IQLIK™, a subcutaneous autoinjector formulation...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US00773J2024
Spyre Therapeutics Inc
SYRE
LISTED
NASDAQ
Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock
News Preview
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory Bowel Disease (“IBD”) and other immune-mediated diseas...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tvardi Therapeutics, Inc. (“Tvardi” or the “Company”) (NASDAQ: TVRD).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 13, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ: LNTH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rul...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
